Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency.
about
The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophilsPeroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogensNeutrophils: Between host defence, immune modulation, and tissue injuryInhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicityTLR signaling and effector functions are intact in XLA neutrophils.Neutropenia in primary immunodeficiencyIRAK-1 contributes to lipopolysaccharide-induced reactive oxygen species generation in macrophages by inducing NOX-1 transcription and Rac1 activation and suppressing the expression of antioxidative enzymes.Reactive nitroxidative species and nociceptive processing: determining the roles for nitric oxide, superoxide, and peroxynitrite in pain.The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes.The multifaceted functions of neutrophils.Regulation of CYBB Gene Expression in Human Phagocytes by a Distant Upstream NF-κB Binding SiteMacrophage-derived IL-1β enhances monosodium urate crystal-triggered NET formation.Thrombin-derived host defence peptide modulates neutrophil rolling and migration in vitro and functional response in vivo.NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice.TLR4-NOX2 axis regulates the phagocytosis and killing of Mycobacterium tuberculosis by macrophages.Bacterial lipoproteins and other factors released by Francisella tularensis modulate human neutrophil lifespan: Effects of a TLR1 SNP on apoptosis inhibition.Neutrophil extracellular traps in acrolein promoted hepatic ischemia reperfusion injury: Therapeutic potential of NOX2 and p38MAPK inhibitors.The ageing immune system and its clinical implications
P2860
Q24306260-C0EA1B66-9D07-4B2F-A113-A636655FF67EQ27025454-885D643E-F078-4A59-88E9-969E1A1A9991Q28087227-6013A66F-D562-47BA-91B7-57E56B746211Q28577454-02A5F87B-BE81-4D29-BC2D-E051E26D5F30Q34137920-F9364700-E22E-4DF8-B0F6-3AE21A17FDACQ37210757-6C81A063-9EF7-44A7-9DE8-E68FCFE4511BQ37467568-A1CD17EA-37FF-43B4-8D0A-E7A6B366BB67Q37765512-A0EB8831-2761-4696-AA5F-633EBD0EE89AQ37825925-D6AF8C8E-BA83-401E-B80F-12CF5B6F9493Q38139589-9D395E7E-D68F-46BB-B82F-11F53EBFD71BQ38902151-4B7C828D-2523-46B2-8AEE-A84B3480C05EQ40448592-FF2230C0-2B5B-432D-B765-3836A6CD6035Q41322040-FE5602A6-6438-4F11-83C7-9DDE27E197AEQ42087034-344DBCA3-D220-4D68-B222-F2897B2CF02DQ47098726-1BD37D8A-4AEF-4184-BFFA-3E4FAB5FAA46Q47732086-65F1B58A-0521-4AE5-82BC-79767C94D059Q47836000-D75509E4-9A06-4F06-8B64-747824931888Q58045474-397C9DEB-476C-4240-9546-19CC897E4CBF
P2860
Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impaired priming and activatio ...... with IRAK4 or NEMO deficiency.
@en
Impaired priming and activatio ...... with IRAK4 or NEMO deficiency.
@nl
type
label
Impaired priming and activatio ...... with IRAK4 or NEMO deficiency.
@en
Impaired priming and activatio ...... with IRAK4 or NEMO deficiency.
@nl
prefLabel
Impaired priming and activatio ...... with IRAK4 or NEMO deficiency.
@en
Impaired priming and activatio ...... with IRAK4 or NEMO deficiency.
@nl
P2093
P2860
P356
P1476
Impaired priming and activatio ...... with IRAK4 or NEMO deficiency.
@en
P2093
Anjali Singh
Douglas B Kuhns
John I Gallin
Kol A Zarember
P2860
P304
P356
10.4049/JIMMUNOL.0802512
P407
P577
2009-05-01T00:00:00Z